|
Synonyms: AGEN-2034 | AGEN2034 | AGEN2034w [6]
Compound class:
Antibody
Comment: Balstilimab (AGEN2034) is an anti-PD-1 checkpoint inhibitor monoclonal antibody. Peptide sequences for the heavy and light chains of balstilimab are claimed in patent US10323091B2 [6], nominally for IgG4 antibody AGEN2034w.
|
Classification ![]() |
|
| Compound class | Antibody |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 10993 | balstilimab |
Synonyms ![]() |
|
| AGEN-2034 | AGEN2034 | AGEN2034w [6] | |
Database Links ![]() |
|
| Specialist databases | |
| IMGT/mAb-DB | 912 |
| Other databases | |
| GtoPdb PubChem SID | 530846839 |
| Search PubMed clinical trials | balstilimab |
| Search PubMed titles | balstilimab |
| Search PubMed titles/abstracts | balstilimab |